5:19 PM
 | 
May 07, 2013
 |  BC Extra  |  Company News

Astellas, Drais form newco to develop Astellas nocturia compound

Astellas Pharma Inc. (Tokyo:4503) and Drais Pharmaceuticals Inc. (Bridgewater, N.J.) partnered to form a virtual company -- Tacurion Pharma Inc. -- to develop and commercialize Astellas' ASP7035 for nocturia. Tacurion will...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >